Israel Englander’s Axsome Therapeutics AXSM Stock Holding History

Israel Englander’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.72M	Sell	15,200 -14,900	-50%	-$3.23M	﹤0.01%	3282
2026 Q1	$5.09M	Buy	+30,100	New	+$5.2M	﹤0.01%	2920
2025 Q2	–	Sell	-25,200	Closed	-$2.94M	–	5851
2025 Q1	$2.94M	Buy	25,200 +12,500	+98%	+$1.42M	﹤0.01%	3415
2024 Q4	$1.07M	Buy	+12,700	New	+$1.17M	﹤0.01%	4144
2023 Q4	–	Sell	-3,800	Closed	-$266K	–	6076
2023 Q3	$266K	Sell	3,800 -24,400	-87%	-$1.82M	﹤0.01%	4997
2023 Q2	$2.03M	Buy	+28,200	New	+$2.08M	﹤0.01%	3469
2022 Q3	–	Sell	-375,000	Closed	-$14.4M	–	7052
2022 Q2	$14.4M	Buy	+375,000	New	+$11.9M	0.01%	1624
2022 Q1	–	Sell	-40,000	Closed	-$1.51M	–	6892
2021 Q4	$1.51M	Buy	40,000 +30,000	+300%	+$1.1M	﹤0.01%	4027
2021 Q3	$330K	Buy	+10,000	New	+$390K	﹤0.01%	5742
2020 Q1	–	Sell	-50,000	Closed	-$5.17M	–	3829
2019 Q4	$5.17M	Buy	+50,000	New	+$2.02M	0.01%	1898
2019 Q2	–	Sell	-20,000	Closed	-$285K	–	4042
2019 Q1	$285K	Buy	+20,000	New	+$186K	﹤0.01%	3571

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Israel Englander's AXSM Position: Q2 2026 in Review

Israel Englander increased its Axsome Therapeutics (AXSM) stake by 2,579% in Q2 2026, buying an estimated $116M and bringing the position to 556,088 shares worth $136M. The position accounts for 0.05% of the portfolio, ranked #381.

Israel Englander first reported a position in AXSM in Q4 2015 and has held it in 36 quarters since. 502 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Israel Englander held 556,088 shares of Axsome Therapeutics worth $136M as of Q2 2026.
Israel Englander bought 535,330 Axsome Therapeutics shares in Q2 2026, an estimated $116M.
Axsome Therapeutics made up 0.05% of Israel Englander's portfolio in Q2 2026, its #381 holding.
Israel Englander first reported a position in Axsome Therapeutics in Q4 2015 and has held it in 36 quarters since.
502 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.